Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (431-440 of 652) with videos related to

Pageof 66
Sort By:
Gastro Hep Advances|May 7, 2026
Significant Increase in <i>Clostridioides difficile</i> Mortality During the COVID-19 Pandemic: A Nationwide StudyJonathan Besney, Christina M Ray, Katherine A Buhler, et al.
CNS Drugs|July 13, 2012
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidenceGabriele Sani, Giulia Serra, Giorgio D Kotzalidis, et al.
The Journal of Nervous and Mental Disease|August 13, 2025
Prodromal Symptoms of Schizophrenia, Childhood Maltreatment, Attachment Insecurity, and Alexithymia: A Correlation Network ApproachLucia Sideli, Andrea Fontana, Lucrezia Trani, et al.
Journal of Crohn'S & Colitis|July 22, 2025
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel reviewSophie Vieujean, Bruce E Sands, Remo Panaccione, et al.
Journal of Crohn'S & Colitis|November 1, 2024
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY StudiesRaja Atreya, Marc Ferrante, Remo Panaccione, et al.
The American Journal of Gastroenterology|March 17, 2025
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND StudiesJoana Torres, Julian Panés, Corey A Siegel, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Canadian Journal of Gastroenterology & Hepatology|June 17, 2015
Ulcerative colitis-associated hospitalization costs: a population-based studyStephanie Coward, Steven J Heitman, Fiona Clement, et al.
Gastroenterology|July 31, 2013
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studiesAlexandra D Frolkis, Jonathan Dykeman, María E Negrón, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 13, 2021
Association Between Celiac Disease and Autism Spectrum Disorder: A Systematic ReviewJoshua Quan, Nicola Panaccione, Jocelyn Jeong, et al.
Pageof 66

Showing results (431-440 of 652) with videos related to

Sort By:
Pageof 66
Gastro Hep Advances|May 7, 2026
Significant Increase in <i>Clostridioides difficile</i> Mortality During the COVID-19 Pandemic: A Nationwide StudyJonathan Besney, Christina M Ray, Katherine A Buhler, et al.
CNS Drugs|July 13, 2012
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidenceGabriele Sani, Giulia Serra, Giorgio D Kotzalidis, et al.
The Journal of Nervous and Mental Disease|August 13, 2025
Prodromal Symptoms of Schizophrenia, Childhood Maltreatment, Attachment Insecurity, and Alexithymia: A Correlation Network ApproachLucia Sideli, Andrea Fontana, Lucrezia Trani, et al.
Journal of Crohn'S & Colitis|July 22, 2025
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel reviewSophie Vieujean, Bruce E Sands, Remo Panaccione, et al.
Journal of Crohn'S & Colitis|November 1, 2024
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY StudiesRaja Atreya, Marc Ferrante, Remo Panaccione, et al.
The American Journal of Gastroenterology|March 17, 2025
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND StudiesJoana Torres, Julian Panés, Corey A Siegel, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Canadian Journal of Gastroenterology & Hepatology|June 17, 2015
Ulcerative colitis-associated hospitalization costs: a population-based studyStephanie Coward, Steven J Heitman, Fiona Clement, et al.
Gastroenterology|July 31, 2013
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studiesAlexandra D Frolkis, Jonathan Dykeman, María E Negrón, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 13, 2021
Association Between Celiac Disease and Autism Spectrum Disorder: A Systematic ReviewJoshua Quan, Nicola Panaccione, Jocelyn Jeong, et al.
Pageof 66